Aptose Biosciences, Inc.
APTO
APTO was delisted on the 1st of April, 2025.
4 hedge funds and large institutions have $35.8K invested in Aptose Biosciences, Inc. in 2025 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
33% more funds holding
Funds holding: 3 → 4 (+1)
27% more capital invested
Capital invested by funds: $28.1K → $35.8K (+$7.68K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FFA
Farther Finance Advisors
San Francisco,
California
|
+$15 |
Top Sellers
APTO Hedge Fund Activity: Q4 2025 in Review
4 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Aptose Biosciences, Inc. (APTO) for Q4 2025, worth a combined $35.8K — up 27% from $28.1K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new APTO positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Farther Finance Advisors, opening a new position worth an estimated $15.
- 4 institutional investors held Aptose Biosciences, Inc. (APTO) as of Q4 2025, up from 3 in Q3 2025.
- Funds reported $35.8K of Aptose Biosciences, Inc. stock for Q4 2025, up 27% quarter-over-quarter.
- 1 fund opened new Aptose Biosciences, Inc. positions in Q4 2025 and 0 closed out, a net change of +1 holder.
- The largest Aptose Biosciences, Inc. buyer in Q4 2025 was Farther Finance Advisors, an estimated $15 added.
Based on aggregated 13F filings for Q4 2025.